欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号EE/H/0311/001
药品名称Imipenem/Cilastatin Venus Pharma
活性成分
    • cilastatin sodium salt 500.0 mg
    • imipenem monohydrate 500.0 mg
剂型Powder for solution for infusion
上市许可持有人Venus Pharma GmbH Am Bahnhof 1-3 Werne North Rhine-Westphalia 59368 Germany
参考成员国 - 产品名称Estonia (EE)
互认成员国 - 产品名称
    • Latvia (LV)
      Imipenem/Cilastatin Venus Pharma 500 mg/500 mg pulveris infūziju šķīduma pagatavošanai
    • Cyprus (CY)
      Imipenem/Cilastatin Venus Pharma, Powder for Solution for Infusion, 500 mg/500 mg
    • Lithuania (LT)
      Imipenem/Cilastatin Venus Pharma 500 mg/500 mg milteliai infuziniam tirpalui
    • Slovenia (SI)
许可日期2021/01/28
最近更新日期2023/10/24
药物ATC编码
    • J01DH51 imipenem and cilastatin
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
    市场状态Positive
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase